AMGN

Amgen Inc. Healthcare - Biotechnology Investor Relations →

NO
60.2% ABOVE
↑ Moving away Was 59.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $290.60
14-Week RSI 63
Rel. Volume (14w) This week's trading vs. the 14-week average 0.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.91

Amgen Inc. (AMGN) closed at $465.67 as of 2026-11-13, trading 60.2% above its 200-week moving average of $290.60. The stock moved further from the line this week, up from 59.1% last week. The 14-week RSI sits at 63, indicating neutral momentum.

Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.91 ratio) is neutral — neither side is clearly dominating.

Over the past 2217 weeks of data, AMGN has crossed below its 200-week moving average 22 times. On average, these episodes lasted 16 weeks. Historically, investors who bought AMGN at the start of these episodes saw an average one-year return of +20.2%.

With a market cap of $251.9 billion, AMGN is a large-cap stock. The company generates a free cash flow yield of 2.9%. Return on equity stands at 78.4%, indicating strong profitability. The stock trades at 17.6x book value.

Over the past 33.9 years, a hypothetical investment of $100 in AMGN would have grown to $9003, compared to $3136 for the S&P 500. That represents an annualized return of 14.2% vs 10.7% for the index — confirming AMGN as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been declining at a -2.7% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: AMGN vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After AMGN Crosses Below the Line?

Across 21 historical episodes, buying AMGN when it crossed below its 200-week moving average produced an average return of +20.4% after 12 months (median +9.0%), compared to +10.1% for the S&P 500 over the same periods. 71% of those episodes were profitable after one year. After 24 months, the average return was +47.0% vs +22.8% for the index.

Each line shows $100 invested at the moment AMGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices AMGN would reach each dislocation threshold.

Current Bean Score -0.84σ
Current FCF Yield 3.80%
Baseline Yield 4.39%
Historical σ 0.28pp

Dislocation Price Levels

Prices where AMGN's Bean Score would hit each σ threshold. Valid until next earnings report: 2027-02-02.

LevelσPriceSignal
Deep Value+2σ$385.71Unusually cheap — analysis point
Value+1σ$410.48Cheap vs. own history
Fair Value+0σ$438.65Historical mean behavior
Expensive-1σ$470.97Expensive vs. own history
Deep Expensive-2σ$508.43Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-11-03$5.78$6.45+11.6%
2026-08-04$5.62$6.29+12.0%
2026-04-30$4.77$5.15+8.0%
2026-02-03$4.73$5.29+11.9%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from AMGN's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation -3.33σ Dividend yield vs own 10-yr norm
Drawdown Score -0.28σ Distance from line vs own history
Sector-Relative -0.67σ Vs sector median this week
Buyback Acceleration N/A YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History -2.8pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+9.5pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

AMGN has crossed below its 200-week MA 22 times with an average 1-year return of +20.2% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
May 1984Apr 19854942.7%+35.6%+595283.3%
Mar 1993Apr 199369.0%+21.8%+16687.2%
May 1993Oct 19932019.9%+29.8%+15623.2%
Jan 1994May 19941518.7%+50.1%+13229.5%
Jun 1994Jul 199479.2%+56.3%+12167.6%
Apr 2002Mar 20034433.9%+29.7%+1329.7%
Nov 2003Dec 200343.1%+3.0%+1097.8%
Mar 2004Aug 2004219.0%+1.5%+1101.1%
Sep 2004Nov 200488.8%+47.5%+1117.7%
Mar 2005Apr 200510.3%+26.9%+1116.6%
Feb 2007Jul 20087436.9%-26.3%+1029.9%
Sep 2008Jul 20094625.4%-2.4%+1055.0%
Aug 2009Sep 200931.5%-12.6%+1070.5%
Sep 2009Oct 200910.9%-5.2%+1091.1%
Oct 2009Jan 2010148.6%+2.5%+1142.2%
Feb 2010Mar 201031.6%-4.9%+1135.3%
May 2010Sep 2010208.6%+5.8%+1181.2%
Nov 2010Dec 201051.8%+6.8%+1180.9%
Feb 2011Apr 2011113.4%+26.6%+1198.3%
Aug 2011Aug 201137.6%+61.0%+1238.7%
May 2023Jun 202331.6%+45.4%+136.8%
Jul 2023Jul 202311.4%+46.6%+134.9%
Average16—+20.2%—

Frequently Asked Questions

Is AMGN below its 200-week moving average?

No. Amgen Inc. (AMGN) is currently 60.2% above its 200-week moving average of $290.60. It would need to fall to $290.60 to cross below the line.

What is AMGN's 200-week moving average price?

Amgen Inc.'s 200-week moving average is $290.60 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when AMGN drops below its 200-week moving average?

AMGN has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +20.2%. These dips have historically been decent entry points. These episodes lasted 16 weeks on average.

Is AMGN a good value right now?

Here's what our data says about AMGN as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 63. Free cash flow yield is 2.9%. Return on equity is 78.4%. Price-to-book is 17.6x. This is not a buy or sell recommendation — always do your own research.

How does AMGN compare to the S&P 500?

Over the past 33.9 years, $100 invested in AMGN would have grown to $9003, compared to $3136 for the S&P 500. That's 14.2% annualized vs 10.7% for the index. AMGN has outperformed the broader market over this period.

Does AMGN pay a dividend?

Yes. Amgen Inc. currently pays a dividend yield of 216.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13